Literature DB >> 11469507

Effects of fosinopril on renal function, baroreflex response and noradrenaline pressor response in conscious normotensive dogs.

C Buranakarl1, A Kijtawornrat, P Nampimoon.   

Abstract

The blood pressure. renal function, baroreflex response of heart rate and noradrenaline (norepinephrine) pressor response were determined in conscious, normotensive, sodium-replete dogs that had received fosinopril. Oral administration of fosinopril at a dose of 1 mg/kg per day for 5 days decreased the systolic arterial pressure from 147.1 +/- 3 to 131.8 +/- 4.3 mmHg (p < 0.05) and the mean arterial pressure from 99.7+/- 3.9 to 87.5 +/- 2.8 mmHg (p < 0.05), while heart rate was unchanged. A study of the noradrenaline pressor response showed a tendency to alleviate the increased MAP by fosinopril treatment, although this was not significant. There were no significant changes in the sensitivity of the baroreflex response in HR, although the setpoint was reduced. After 7 days of fosinopril treatment, the glomerular filtration rate had increased by 18.5% (p < 0.05). The effective renal plasma flow tended to increase, leaving the filtration fraction unchanged. The renal vascular resistance was reduced by 11.3% (p < 0.05). Fosinopril caused a significant 41.5% increase in urinary excretion of Na+ (p < 0.05), along with an elevation of urinary excretion of K+ and Cl- . It is concluded that fosinopril can lower the blood pressure, reduce the noradrenaline pressor response and lower the cardiac baroreflex setpoint to noradrenaline. Oral administration of fosinopril for 7 days affects both the renal haemodynamics and electrolyte excretions in conscious, normotensive, sodium-replete dogs.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11469507     DOI: 10.1023/a:1010638609216

Source DB:  PubMed          Journal:  Vet Res Commun        ISSN: 0165-7380            Impact factor:   2.459


  30 in total

1.  Immediate and short-term cardiovascular effects of fosinopril, a new angiotensin-converting enzyme inhibitor, in patients with essential hypertension.

Authors:  S Oren; F H Messerli; E Grossman; G E Garavaglia; E D Frohlich
Journal:  J Am Coll Cardiol       Date:  1991-04       Impact factor: 24.094

2.  Analysis of the action of angiotensin II on the baroreflex control of heart rate in conscious rabbits.

Authors:  I A Reid; L Chou
Journal:  Endocrinology       Date:  1990-05       Impact factor: 4.736

Review 3.  Clinical pharmacokinetics of the newer ACE inhibitors. A review.

Authors:  J G Kelly; K O'Malley
Journal:  Clin Pharmacokinet       Date:  1990-09       Impact factor: 6.447

4.  Blood pressure lowering and renal hemodynamic effects of fosinopril in conscious animal models.

Authors:  J M DeForrest; T L Waldron; C Harvey; B Scalese; S Mitch; J R Powell; W Petrillo; D W Cushman
Journal:  J Cardiovasc Pharmacol       Date:  1990-07       Impact factor: 3.105

5.  Effect of intrarenal angiotensin II blockade on renal function in conscious dogs.

Authors:  H M Kimbrough; E D Vaughan; R M Carey; C R Ayers
Journal:  Circ Res       Date:  1977-02       Impact factor: 17.367

6.  Effects of the nonpeptide angiotensin II receptor antagonist DuP 753 on blood pressure and renal functions in spontaneously hypertensive PH dogs.

Authors:  K C Bovee; P C Wong; P B Timmermans; M J Thoolen
Journal:  Am J Hypertens       Date:  1991-04       Impact factor: 2.689

7.  Combined versus single effect of fosinopril and hydrochlorothiazide in hypertensive patients.

Authors:  M Fernández; R Madero; D González; P Camacho; J Villalpando; J Arriaga
Journal:  Hypertension       Date:  1994-01       Impact factor: 10.190

8.  Effects of low and high doses of fosinopril on the structure and function of resistance arteries.

Authors:  D Rizzoni; M Castellano; E Porteri; G Bettoni; M L Muiesan; A Cinelli; E A Rosei
Journal:  Hypertension       Date:  1995-07       Impact factor: 10.190

9.  Mechanism of action of enalapril in experimental hypertension and acute left ventricular failure.

Authors:  C S Sweet; S L Gaul; P M Reitz; E H Blaine; L T Ribeiro
Journal:  J Hypertens Suppl       Date:  1983-10

10.  Vascular wall renin in spontaneously hypertensive rats. Potential relevance to hypertension maintenance and antihypertensive effect of captopril.

Authors:  M M Asaad; M J Antonaccio
Journal:  Hypertension       Date:  1982 Jul-Aug       Impact factor: 10.190

View more
  2 in total

1.  Effects of brimonidine ingestion on cardiovascular responses and renal function in conscious dogs.

Authors:  S Suwanwipat; C Buranakarl; N Chaiyabutr
Journal:  Vet Res Commun       Date:  2006-12-28       Impact factor: 2.459

2.  Relationships between degree of azotaemia and blood pressure, urinary protein:creatinine ratio and fractional excretion of electrolytes in dogs with renal azotaemia.

Authors:  C Buranakarl; K Ankanaporn; S Thammacharoen; M Trisiriroj; T Maleeratmongkol; P Thongchai; S Panasjaroen
Journal:  Vet Res Commun       Date:  2006-12-20       Impact factor: 2.459

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.